Related Experiment Video

Updated: Jan 22, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

12.3K

Cost-Effectiveness of Cardiac Rehabilitation in Patients with Coronary Artery Disease: A Meta-Analysis

Tomoyuki Takura1, Nozomi Ebata-Kogure2, Yoichi Goto3

  • 1Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.

Cardiology Research and Practice
|July 6, 2019
PubMed

Insights

Cardiac rehabilitation (CR) significantly improves quality-adjusted life years (QALYs) for coronary artery disease patients. This meta-analysis indicates CR is a potentially cost-effective therapy, offering improved cost per QALY compared to usual care.

Area of Science:

  • Cardiology
  • Health Economics

Background:

  • Rising global medical costs for cardiovascular disease necessitate cost-effective treatments.
  • Economic evaluations of cardiac rehabilitation (CR) are limited, particularly meta-analyses comparing costs and patient outcomes.

Purpose of the Study:

  • To conduct a meta-analysis evaluating the cost-effectiveness of cardiac rehabilitation (CR) versus usual care (UC) for coronary artery disease (CAD) patients.
  • To assess medical costs, quality-adjusted life year (QALY), and life year (LY) outcomes associated with CR.

Main Methods:

  • Meta-analysis of 5 studies involving 122,485 patients with coronary artery disease (CAD), including convalescent and comprehensive CR populations.
  • Evaluation of medical costs, QALY, LY, and incremental cost-utility ratios (ICURs).
  • Comparison of CR versus usual care (UC) using risk ratio (RR) and standardized mean difference (SMD).

Main Results:

  • CR significantly improved QALY (SMD: -1.78) compared to UC.
  • While CR had slightly higher medical costs (SMD: 0.02), it significantly improved cost per QALY (SMD: -0.31).
  • ICURs indicated that CR was dominant (cheaper and more effective) in some cases and cost-effective (<$50,000 USD/QALY) in others.

Conclusions:

  • Cardiac rehabilitation (CR) demonstrates potential cost-effectiveness for patients with coronary artery disease.
  • Despite data limitations, CR offers improved QALY and favorable cost-effectiveness ratios compared to usual care.
Abstract

More Related Videos

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

818
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.6K

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
912
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
390
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
222
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
342
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
606
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
333